Latest Insider Transactions at Ardelyx, Inc. (ARDX)
This section provides a real-time view of insider transactions for Ardelyx, Inc. (ARDX). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of ARDELYX, INC. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of ARDELYX, INC.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 09
2021
|
Scott D Sandell > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
669,483
-4.91%
|
$669,483
$1.51 P/Share
|
|
Nov 22
2021
|
Elizabeth A Grammer Officer |
SELL
Open market or private sale
|
Direct |
537
-0.19%
|
$0
$0.99 P/Share
|
|
Nov 22
2021
|
Robert Blanks Officer |
SELL
Open market or private sale
|
Direct |
643
-0.18%
|
$0
$0.99 P/Share
|
|
Nov 22
2021
|
Jeffrey W Jacobs Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
5,754
-2.31%
|
$0
$0.99 P/Share
|
|
Nov 22
2021
|
Michael Raab President & CEO |
SELL
Open market or private sale
|
Direct |
2,607
-0.41%
|
$0
$0.99 P/Share
|
|
Nov 22
2021
|
Justin A Renz Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
643
-0.22%
|
$0
$0.99 P/Share
|
|
Nov 22
2021
|
Susan Rodriguez Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
643
-0.33%
|
$0
$0.99 P/Share
|
|
Nov 22
2021
|
David P. Rosenbaum Chief Development Officer |
SELL
Open market or private sale
|
Indirect |
184
-0.2%
|
$0
$0.99 P/Share
|
|
Nov 22
2021
|
David P. Rosenbaum Chief Development Officer |
SELL
Open market or private sale
|
Direct |
643
-0.21%
|
$0
$0.99 P/Share
|
|
Nov 15
2021
|
Jeffrey W Jacobs Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
5,000
-3.84%
|
$5,000
$1.13 P/Share
|
|
Nov 12
2021
|
Elizabeth A Grammer Officer |
SELL
Open market or private sale
|
Direct |
77,432
-21.88%
|
$77,432
$1.12 P/Share
|
|
Nov 08
2021
|
Jeffrey W Jacobs Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
2,166
-1.64%
|
$2,166
$1.18 P/Share
|
|
Oct 08
2021
|
Elizabeth A Grammer Officer |
SELL
Grant, award, or other acquisition
|
Direct |
250,000
-41.4%
|
-
|
|
Oct 08
2021
|
Justin A Renz Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
250,000
+45.93%
|
-
|
|
Oct 08
2021
|
Robert Blanks Officer |
BUY
Grant, award, or other acquisition
|
Direct |
250,000
+40.88%
|
-
|
|
Oct 08
2021
|
Susan Rodriguez Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
150,000
+43.14%
|
-
|
|
Oct 08
2021
|
David P. Rosenbaum Chief Development Officer |
BUY
Grant, award, or other acquisition
|
Indirect |
60,000
+39.78%
|
-
|
|
Oct 08
2021
|
David P. Rosenbaum Chief Development Officer |
BUY
Grant, award, or other acquisition
|
Direct |
150,000
+32.48%
|
-
|
|
Oct 08
2021
|
Michael Raab President & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
300,000
+32.11%
|
-
|
|
Aug 20
2021
|
Robert Blanks Officer |
SELL
Open market or private sale
|
Direct |
631
-0.59%
|
$631
$1.32 P/Share
|
|
Aug 20
2021
|
Elizabeth A Grammer Officer |
SELL
Open market or private sale
|
Direct |
526
-0.51%
|
$526
$1.32 P/Share
|
|
Aug 20
2021
|
Jeffrey W Jacobs Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
741
-0.58%
|
$741
$1.32 P/Share
|
|
Aug 20
2021
|
Michael Raab President & CEO |
SELL
Open market or private sale
|
Direct |
2,573
-0.77%
|
$2,573
$1.32 P/Share
|
|
Aug 20
2021
|
Justin A Renz Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
631
-1.55%
|
$631
$1.32 P/Share
|
|
Aug 20
2021
|
Susan Rodriguez Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
630
-1.39%
|
$630
$1.32 P/Share
|
|
Aug 20
2021
|
David P. Rosenbaum Chief Development Officer |
SELL
Open market or private sale
|
Indirect |
176
-0.66%
|
$176
$1.32 P/Share
|
|
Aug 20
2021
|
David P. Rosenbaum Chief Development Officer |
SELL
Open market or private sale
|
Direct |
631
-0.4%
|
$631
$1.32 P/Share
|
|
Aug 03
2021
|
Jeffrey W Jacobs Chief Scientific Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
5,613
-4.19%
|
$5,613
$1.64 P/Share
|
|
Aug 03
2021
|
Jeffrey W Jacobs Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+6.94%
|
$0
$0.54 P/Share
|
|
Aug 03
2021
|
Michael Raab President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
150,343
-31.15%
|
$150,343
$1.64 P/Share
|
|
Aug 03
2021
|
Michael Raab President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
267,892
+35.69%
|
$0
$0.54 P/Share
|
|
Jun 16
2021
|
Jan M Lundberg Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,181
+14.37%
|
-
|
|
Jun 16
2021
|
Richard J Rodgers Director |
BUY
Grant, award, or other acquisition
|
Direct |
9,917
+10.18%
|
-
|
|
Jun 16
2021
|
William C Bertrand Jr Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,891
+9.62%
|
-
|
|
Jun 15
2021
|
Jeffrey W Jacobs Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
7,500
-5.7%
|
$52,500
$7.29 P/Share
|
|
Jun 15
2021
|
Jeffrey W Jacobs Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,500
+5.39%
|
$0
$0.54 P/Share
|
|
May 28
2021
|
David P. Rosenbaum Chief Development Officer |
SELL
Open market or private sale
|
Indirect |
3,062
-10.27%
|
$21,434
$7.22 P/Share
|
|
May 20
2021
|
Robert Blanks Officer |
SELL
Open market or private sale
|
Direct |
612
-0.57%
|
$4,284
$7.09 P/Share
|
|
May 20
2021
|
Elizabeth A Grammer Officer |
SELL
Open market or private sale
|
Direct |
508
-0.49%
|
$3,556
$7.09 P/Share
|
|
May 20
2021
|
Jeffrey W Jacobs Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
721
-0.58%
|
$5,047
$7.09 P/Share
|
|
May 20
2021
|
Michael Raab President & CEO |
SELL
Open market or private sale
|
Direct |
2,534
-1.17%
|
$17,738
$7.09 P/Share
|
|
May 20
2021
|
Justin A Renz Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
612
-1.48%
|
$4,284
$7.09 P/Share
|
|
May 20
2021
|
Susan Rodriguez Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
611
-1.33%
|
$4,277
$7.09 P/Share
|
|
May 20
2021
|
David P. Rosenbaum Chief Development Officer |
SELL
Open market or private sale
|
Indirect |
157
-0.52%
|
$1,099
$7.09 P/Share
|
|
May 20
2021
|
David P. Rosenbaum Chief Development Officer |
SELL
Open market or private sale
|
Direct |
612
-0.38%
|
$4,284
$7.09 P/Share
|
|
Apr 06
2021
|
Robert Blanks Officer |
SELL
Open market or private sale
|
Direct |
5,163
-2.31%
|
$41,304
$8.0 P/Share
|
|
Apr 06
2021
|
David P. Rosenbaum Chief Development Officer |
SELL
Open market or private sale
|
Direct |
5,000
-3.03%
|
$40,000
$8.0 P/Share
|
|
Feb 22
2021
|
Elizabeth A Grammer Officer |
SELL
Open market or private sale
|
Direct |
504
-0.49%
|
$3,024
$6.88 P/Share
|
|
Feb 22
2021
|
Justin A Renz Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
608
-1.45%
|
$3,648
$6.88 P/Share
|
|
Feb 22
2021
|
David P. Rosenbaum Chief Development Officer |
SELL
Open market or private sale
|
Indirect |
193
-0.64%
|
$1,158
$6.88 P/Share
|